ClinicalTrials.gg
Drug

Resiquimod clinical trials

Also written R848.

studies test it
16
open now
1
in phase 3
0
first study started
2004

How each study uses resiquimod is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the resiquimod studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Resiquimod
9

Development codes

R848
3

Studies by the year they started

16 studies that test it; most in 2004 (4)

Studies that test resiquimod, by start year
YearStudies
20044
20053
20061
20091
20123
20131
20171
20221
20241

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
4
Phase 2
11
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 7

Graceway Pharmaceuticals, LLC (6) · Mayo Clinic (2) · University of British Columbia (2) · Cambridge University Hospitals NHS Foundation Trust (1) · Galderma R&D (1) · Abramson Cancer Center at Penn Medicine (1) · Celldex Therapeutics (1) · Spirig Pharma Ltd. (1)

Often tested with

Tested in the same studies.

Resiquimod Gel CD11301 (1) · Gag:267-274 Peptide Vaccine (1) · Rasdegafusp alfa (1) · Poly ICLC (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test resiquimod.

Studies

Open first, then newest update. How each study uses resiquimod is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 16

Codes

What other systems call resiquimod · ClinicalTrials.gg INT004198

  • MeSH (NLM) C402365resiquimodConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) V3DMU7PVXFRESIQUIMODConfirmed FDA, NLM, Wikidata
  • Wikidata Q426054resiquimodConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C63958ResiquimodOne source FDA
  • DrugBank DB06530One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.